Banque Transatlantique Sa Anavex Life Sciences Corp. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Banque Transatlantique Sa holds 470 shares of AVXL stock, worth $3,539. This represents 0.0% of its overall portfolio holdings.
Number of Shares
470Holding current value
$3,539% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
203Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$48.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$36.9 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$24.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$14.8 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$7.53 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $587M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...